Measuring what matters in sleep disorder trials: A guide to COA selection
Sleep disorders are a growing global health burden. Conditions like insomnia affect an estimated 852 million adults worldwide, and obstructive sleep apnea affects an estimated 936 million adults globally. These, along with other conditions such as restless legs syndrome, narcolepsy, and REM sleep behavior disorders, influence energy levels, concentration, emotional well-being, daily activities, work productivity, and overall quality of life.
Though traditional sleep assessments help researchers understand what happens during sleep, physiological measures do not capture how patients feel and function during the day. Which is why researchers use Clinical Outcome Assessments to understand the patient's lived experience and assess whether treatment is making a difference in everyday life.
Mapi Research Trust's new guide, Measuring What Matters in Sleep Disorders, explores:
- Why patient-centered outcomes matter in sleep trials
- Current regulatory expectations for COA selection
- Key instruments used across insomnia, OSA, narcolepsy, RLS, and RBD research
- How to build a fit-for-purpose endpoint strategy that reflects what matters most to patients
Simplifying COA selection and implementation
Selecting the right COA is one part of developing an effective endpoint strategy. Sponsors must also evaluate the supporting evidence, identify measurement gaps, secure instrument licenses, and prepare COAs for use across study populations and geographies.
Mapi Research Trust helps sponsors navigate all of these requirements. Our team brings together scientific expertise, instrument intelligence, and licensing support to reduce the work involved in selecting and implementing fit-for-purpose COAs.
Our services include:
- COA evidence and selection: Instrument intelligence, targeted literature reviews, concept mapping, and gap analyses
- Scientific research and development: Patient interviews, qualitative research, rater reliability assessments, and de novo instrument development
- Digital measurement: Evaluation of digital health technologies (DHTs) with the Atlas platform for digital measures
- Licensing and distribution: Access to COAs and streamlined licensing through ePROVIDE
- Translation and linguistic validation: Translation and linguistic validation services through ICON to support consistent measurement across languages and cultures
By bringing these capabilities together, MRT helps sponsors reduce the coordination required to develop and implement their COA strategies. Reach out to our team to discuss your needs.
If you're designing a sleep study or refining your endpoint strategy, our guide offers a practical overview of the COAs in sleep and their measurement approaches to help researchers better understand treatment benefit.